View Information Collection Request (ICR) Package

OMB Control No: 1117-0004	ICR Reference No: 200608-1117-004
Status: Historical Inactive	Previous ICR Reference No: 200501-1117-004
Agency/Subagency: DOJ/DEA	Agency Tracking No:
Title: Application for Permit to Export Controlled Substances
Type of Information Collection: Revision of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Withdrawn	Conclusion Date: 01/17/2007
	Date Received in OIRA: 10/26/2006
Terms of Clearance: Withdrawn per DEA memo submitted to OMB 01/16/2007.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date		36 Months From Approved	04/30/2008
Responses	0	0	2,444
Time Burden (Hours)	0	0	1,222
Cost Burden (Dollars)	0	0	0

Abstract: Title 21 CFR §§ 1312.21 and 1312.22 require persons who export controlled substances in Schedules I and II and who reexport controlled substances in Schedules I and II and narcotic controlled substances in Schedules III and IV to obtain a permit from DEA. Information is used to issue export permits, exercise control over exportation of controlled substances, and compile data for submission to the United Nations to comply with treaty requirements.

Authorizing Statute(s): US Code: 21 USC 953 Name of Law: Substances Export Reform Act of 2005

Citations for New Statutory Requirements: US Code: 21 USC 953 Name of Law: Controlled Substances Import and Export Act

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
1117-AB00	Proposed rulemaking	71 FR 61436	10/18/2006

Federal Register Notices & Comments
Did the Agency receive public comments on this ICR? No

Number of Information Collection (IC) in this ICR: 2

IC Title	Form No.	Form Name
Application for Permit to Export Controlled Substances--DEA Form 161	DEA Form 161
Application for Permit to Export Controlled Substances--DEA Form 161r	DEA Form 161-r

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: There has been a program change. The Controlled Substances Export Reform Act of 2005 (Pub. L. 109-57) permits the exportation of Schedule I and II and narcotic Schedule III and IV controlled substances to a country for subsequent exportation to a second country and requires documentation that the controlled substances have been reexported to a second country. Previous law did not allow this. Because of this change, DEA has created a new Form 161r, Application for Permit to Export Controlled Substances for Subsequent Reexport. Further, DEA is requiring that persons reexporting controlled substances notify DEA of the initial export of those controlled substances to the first country, necessitating an increase in hour burden of 100 hours. Finally, changes made by Pub. L. 109-57 require that certification of reexportation be provided to DEA; this certification is a new aspect of this collection, necessitating an increase in hour burden of 300 hours. Although DEA estimates that it takes 15 more minutes (0.25 more hours) to complete DEA Form 161r, Application for Permit to Export Controlled Substances for Subsequent Reexport, as compared with DEA Form 161, Application for Permit to Export Controlled Substances, this increase in time for the new Form 161r is offset by the need to submit fewer DEA Forms 161. Previously, reexportation of Schedule I and II controlled substances and narcotic controlled substances in Schedule III and IV, was not permitted; persons exporting controlled substances sent them to the actual country of destination, rather than sending them to one country and then reexporting them to the (second) country of destination. Thus, individual DEA Forms 161 were required to handle each individual country of destination. DEA anticipates fewer DEA Forms 161 being submitted now that reexportation of these specific controlled substances is permitted.

Annual Cost to Federal Government: $159,140

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

Agency Contact: Mark Caverly 202 307-7297

View ICR - OIRA Conclusion